News

Info days, brokerage events and matchmaking platforms - Horizon Europe work programme 2026-2027 - 2026 call topics

Published on
| 11 months ago
Programmes
  • ERC
  • MSCA
  • Research Infrastructures
  • Health
  • Culture and society
  • Digital, Industry & Space
  • Climate, Energy, Mobility
  • Agro-Food, Environment
  • Widening/Spreading
  • Enhancing EU R&I
  • Missions

The European Commission and/or its agencies organise info days on the 2026 call topics and these are often complemented by brokerage events, organised by National Contact Point (NCP) networks and/or the Enterprise Europe Network (EEN). These events provide opportunities to connect with potential collaboration partners. In addition, several programmes offer dedicated matchmaking platforms to facilitate partner searches.

Here is an overview of the upcoming info days and brokerage events with the link to the event webpage, which you can find in our event calendar as well. When new dates and information will be made known subsequently this overview will be updated. The matchmaking platforms are included in the overview as well.

Pillar 1

  • European Research Council (ERC)

29/04/2026 mERCury webinar - Towards an ERC Advanced Grant: From groundbreaking idea to successful proposal

  • Marie Sklodowska-Curie Actions (MSCA)

Radiance MSCA Matchmaking Platform

16/02/2026 Networking and Brokerage Event on MSCA Staff Exchanges Call 2026 – Ukraine 

23/02/2026 International Brokerage Event on Horizon Europe MSCA Staff Exchanges

03/03/2026 Q&A session MSCA Staff Exchanges call 2026 (REA)

03/06/2026 MSCA Doctoral Networks 2026 Call info day (REA&EAC)

  • Research infrastructures

18/03/2026 (info day)

1-4/06/2026 (RICH Europe Proposal Check Workshop 2026 for Horizon Europe Research Infrastructure Topics)

Pillar 2

  04/03/2026 (info day)

Clusters 1, 2, 4, 5, 6 and EU Mission Cities with STEM or SSH expertise relevant to AI - Artificial intelligence in Horizon Europe calls: an interdisciplinary challenge 25/2/2026 (brokerage event - 2026 and 2027 call topics)

Horizontal

More information about the publication of the Horizon Europe Main Work Programme 2026-2027 can be found in this NCP Flanders news article.

Related news

myOverview

Sign up for personalised information

Stay informed about Horizon Europe, Digital Europe & EDF, filtered on what matters to you.

  • News in your domains
  • Event announcements
  • A personal dashboard
Sign up now

Only for stakeholders located in Flanders

Latest news

2071 articles available Browse all news
  • Defence
  • NATO-EDA

NATO Engine pilot opens second RFI

The NATO Support and Procurement Agency has launched a second request for information for the NATO Engine pilot. The call targets start-ups, SMEs and scale-ups looking for production capacity for defence or dual-use projects. Registration opened on 17 November 2026 and closes on 31 December 2026.

Read more
  • AI Continent
  • European Digital Innovation Hubs

Call for European AI providers opens

The European Commission’s AI Office has launched a call for expression of interest for European AI providers with mature solutions for SMEs. Selected solutions are due to be listed as “EDIH Ready” in a catalogue on the AI-on-Demand Platform and shared with the European Digital Innovation Hubs network. Expressions of interest must be submitted by 17 December 2026 at 17.00 CET, although the call may close earlier after 100 suitable submissions.

Read more

Testimonial

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.